Article

Diagnostic techniques for the glaucoma patient with OSD

Accurate diagnosis of ocular surface disease (OSD) is essential in patients with glaucoma who complain of burning, itching, foreign body sensation, or a dry, gritty sensation often in concert with paradoxical tearing.

Accurate diagnosis of ocular surface disease (OSD) is essential in patients with glaucoma who complain of burning, itching, foreign body sensation, or a dry, gritty sensation often in concert with paradoxical tearing.

Table 1 on Page 28 illustrates common signs of OSD. Once a firm diagnosis of OSD has been achieved, only then can eye-care practitioners begin to address the issue and effectively treat their patients.

As summarized in Table 2 many useful diagnostic tests are available to the eye-care practitioner. In my opinion, the single most useful diagnostic test available is lissamine green staining. Lissamine green is available in strips or liquid, does not sting the patient's eyes when applied, and can provide a diagnosis of OSD in seconds whereby punctuate corneal epithelial changes are noted.

The Schirmer tear test is a rapid, simple evaluation of tear production. Although the Schirmer tear test has fallen out of favor due to difficulty in interpreting results, this test remains a useful source of information that should be included in every patient's work-up.

Direct visualization of the ocular surface, lid margins, conjunctiva, etc., can be achieved easily by slit lamp examination. In fact, conjunctival inflammation can be readily observed by direct observation of the bulbar conjunctiva.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.